Capricor Therapeutics Company Profile (OTCMKTS:CAPR)

About Capricor Therapeutics

Capricor Therapeutics logoCapricor Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company develops and commercializes regenerative medicine and large molecule products for the treatment of disease, with a primary focus on cardiovascular diseases. The Company has six drug candidates in stages of development, which include CAP-1002, CAP-1001, CSps, Exosomes, Cenderitide (CD-NP) and CU-NP. The Company's technology is based in cardiospheres (CSps), which are multi-cell clusters of cardiac derived cells. The Company's product candidate, the cardiosphere-derived cells (CDC), is the single cell monolayer product of the CSps. Both CSps and CDCs are derived from a deceased human donor (allogeneic source) or from heart tissue taken directly from recipient patients themselves (autologous source).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: CAPR
  • CUSIP:
Key Metrics:
  • Previous Close: $3.40
  • 50 Day Moving Average: $3.8086
  • 200 Day Moving Average: $3.3379
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.07
  • P/E Growth: 0.0000
  • Market Cap: $62.84M
  • Outstanding Shares: 17,954,000
Additional Links:
Companies Related to Capricor Therapeutics:

Analyst Ratings

Consensus Ratings for Capricor Therapeutics (OTCMKTS:CAPR) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.50

Analysts' Ratings History for Capricor Therapeutics (OTCMKTS:CAPR)
Show:
DateFirmActionRatingPrice TargetDetails
7/6/2016HC WainwrightInitiated CoverageBuy$13.00View Rating Details
6/15/2016Roth CapitalInitiated CoverageBuy$12.00View Rating Details
(Data available from 8/28/2014 forward)

Earnings

Earnings History for Capricor Therapeutics (OTCMKTS:CAPR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/15/2016Q2($0.24)($0.26)$1.21 millionViewListenView Earnings Details
5/12/2016Q116($0.19)($0.26)$1.10 millionViewListenView Earnings Details
3/17/2016Q415($0.19)($0.21)$1.10 millionViewN/AView Earnings Details
11/12/2015Q315($0.26)($0.18)$1.10 millionViewN/AView Earnings Details
8/13/2015Q215($0.26)($0.19)$1.10 millionViewN/AView Earnings Details
5/12/2015($0.14)($0.23)ViewN/AView Earnings Details
4/15/2015($0.14)($0.16)ViewN/AView Earnings Details
11/14/2014($0.22)($0.13)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Capricor Therapeutics (OTCMKTS:CAPR)
Current Year EPS Consensus Estimate: $-1.0400 EPS
Next Year EPS Consensus Estimate: $-0.8600 EPS

Dividends

Dividend History for Capricor Therapeutics (OTCMKTS:CAPR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Capricor Therapeutics (OTCMKTS:CAPR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/16/2016Anthony BergmannVPBuy2,030$2.40$4,872.00View SEC Filing  
3/16/2016Karen KrasneyEVPBuy4,060$2.40$9,744.00View SEC Filing  
3/16/2016Leland GershellCFOBuy2,100$2.40$5,040.00View SEC Filing  
3/16/2016Linda MarbanCEOBuy10,152$2.40$24,364.80View SEC Filing  
3/16/2016Louis J GrasmickDirectorBuy91,369$2.40$219,285.60View SEC Filing  
3/16/2016Sinai Medical Center CedarsMajor ShareholderBuy416,666$2.40$999,998.40View SEC Filing  
8/20/2015Louis J. GrasmickDirectorBuy11,900$4.11$48,909.00View SEC Filing  
8/19/2015Eduardo Marbanmajor shareholderBuy18,400$4.36$80,224.00View SEC Filing  
1/21/2015Joshua A KazamDirectorBuy7,096$3.52$24,977.92View SEC Filing  
1/21/2015Sinai Medical Center CedarsMajor ShareholderBuy851,546$3.52$2,997,441.92View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Capricor Therapeutics (OTCMKTS:CAPR)
DateHeadline
News IconAcute Heart Failure - Pipeline Review, H2 2016 - New Market Report (OTCMKTS:CAPR)
reports.pr-inside.com - August 23 at 9:18 PM
News IconCapricor Therapeutics Reports Second Quarter 2016 Financial Results and (OTCMKTS:CAPR)
www.biomedreports.com - August 15 at 9:41 PM
reuters.com logoBRIEF-Capricor Therapeutics Q2 loss per share $0.26 (OTCMKTS:CAPR)
www.reuters.com - August 15 at 9:41 PM
4-traders.com logoCapricor Therapeutics : reports 2Q loss (OTCMKTS:CAPR)
www.4-traders.com - August 15 at 9:41 PM
seekingalpha.com logoCapricor Therapeutics' (CAPR) CEO Linda Marbán on Q2 2016 Results - Earnings Call Transcript (OTCMKTS:CAPR)
seekingalpha.com - August 15 at 9:41 PM
finance.yahoo.com logoCapricor Therapeutics Reports Second Quarter 2016 Financial Results and Provides Clinical Update (OTCMKTS:CAPR)
finance.yahoo.com - August 15 at 4:13 PM
publicnow.com logoInvestor Calendar Invites You to the Capricor Therapeutics Second Quarter 2016 Earnings Conference Call and Webcast Live on Monday, August 15, 2016 (OTCMKTS:CAPR)
www.publicnow.com - August 15 at 11:17 AM
finance.yahoo.com logoCapricor Therapeutics to Hold Second Quarter 2016 Business Update and Financial Results Conference Call … (OTCMKTS:CAPR)
finance.yahoo.com - August 13 at 12:02 PM
publicnow.com logoCapricor Therapeutics to Hold Second Quarter 2016 Business Update and Financial Results Conference Call and Webcast on Monday, August 15 at 4:30 p.m. ET (OTCMKTS:CAPR)
www.publicnow.com - August 12 at 12:42 PM
biz.yahoo.com logoCAPRICOR THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure (OTCMKTS:CAPR)
biz.yahoo.com - August 1 at 4:00 PM
publicnow.com logoCapricor Therapeutics Provides Enrollment Update on HOPE Clinical Trial in Duchenne Muscular Dystrophy (OTCMKTS:CAPR)
www.publicnow.com - June 23 at 9:09 AM
finance.yahoo.com logoCapricor Therapeutics to Present at JMP Life Sciences Conference (OTCMKTS:CAPR)
finance.yahoo.com - June 22 at 4:12 PM
streetinsider.com logoCapricor Therapeutics (CAPR) Announces Statistically Significant Data on CAP-1002 in Adv. Heart Failure (OTCMKTS:CAPR)
www.streetinsider.com - June 16 at 4:03 PM
schaeffersresearch.com logoCapricor Therapeutics Inc (CAPR) Stock Soars on Drug Data (OTCMKTS:CAPR)
www.schaeffersresearch.com - June 16 at 4:03 PM
publicnow.com logoCapricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial (OTCMKTS:CAPR)
www.publicnow.com - June 16 at 10:39 AM
finance.yahoo.com logo8:31 am Capricor Therapeutics: CAP-1002 demonstrates durable efficacy signal over 12 months in patients with advanced heart failure (OTCMKTS:CAPR)
finance.yahoo.com - June 16 at 8:31 AM
finance.yahoo.com logoCoverage initiated on Capricor Therapeutics by ROTH Capital (OTCMKTS:CAPR)
finance.yahoo.com - June 15 at 7:03 AM
fxpips.com logoGaps Down Stocks Highlight – URRE, CAPR, CATB, FLXN, ASC, PAY (OTCMKTS:CAPR)
www.fxpips.com - June 9 at 4:04 PM
4-traders.com logoCAPRICOR THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) (OTCMKTS:CAPR)
www.4-traders.com - June 7 at 4:04 PM
biz.yahoo.com logoCAPRICOR THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (OTCMKTS:CAPR)
biz.yahoo.com - June 6 at 5:31 PM
publicnow.com logoCapricor Therapeutics to Present at 2016 BIO International Convention (OTCMKTS:CAPR)
www.publicnow.com - May 31 at 7:12 AM
capitalcube.com logoCapricor Therapeutics, Inc. :CAPR-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 (OTCMKTS:CAPR)
www.capitalcube.com - May 23 at 12:37 PM
4-traders.com logoCAPRICOR THERAPEUTICS : Change in Directors or Principal Officers (form 8-K) (OTCMKTS:CAPR)
www.4-traders.com - February 26 at 1:47 PM
biz.yahoo.com logoCAPRICOR THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (OTCMKTS:CAPR)
biz.yahoo.com - February 25 at 6:10 AM
finance.yahoo.com logoCapricor Therapeutics Appoints Leland J. Gershell, M.D., Ph.D. as Chief Financial Officer (OTCMKTS:CAPR)
finance.yahoo.com - February 23 at 9:00 AM
biz.yahoo.com logoCAPRICOR THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (OTCMKTS:CAPR)
biz.yahoo.com - February 22 at 8:01 AM
finance.yahoo.com logoCapricor Therapeutics Announces the First Patient with Duchenne Muscular Dystrophy-Related Cardiomyopathy Treated with CAP-1002 in the HOPE-Duchenne Phase I/II Clinical Trial (OTCMKTS:CAPR)
finance.yahoo.com - February 22 at 8:00 AM
finance.yahoo.com logoCapricor Therapeutics to Present at 18th Annual BIO CEO & Investor Conference (OTCMKTS:CAPR)
finance.yahoo.com - February 2 at 7:00 AM
finance.yahoo.com logoAlign Technology Tops Q4 Earnings, Revenues; Margins Drop (OTCMKTS:CAPR)
finance.yahoo.com - January 29 at 11:20 AM
finance.yahoo.com logoThermo Fisher Tops Q4 Earnings, Affymetrix Buy in the Cards (OTCMKTS:CAPR)
finance.yahoo.com - January 28 at 2:22 PM
zacks.com logoGNC Unveils 2015 Preliminary Outcome; Earnings Beat Likely (OTCMKTS:CAPR)
www.zacks.com - January 20 at 1:21 PM
noodls.com logoCapricor Therapeutics to Present at Biotech Showcase 2016 (OTCMKTS:CAPR)
www.noodls.com - January 5 at 7:28 AM
capitalcube.com logoCapricor Therapeutics, Inc. Earnings Analysis: Q3, 2015 By the Numbers (OTCMKTS:CAPR)
www.capitalcube.com - December 17 at 11:19 AM
biz.yahoo.com logoCAPRICOR THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (OTCMKTS:CAPR)
biz.yahoo.com - December 10 at 5:05 PM
noodls.com logoCapricor Therapeutics to Present at the 2015 JMP Securities DMD Forum (OTCMKTS:CAPR)
www.noodls.com - December 10 at 9:19 AM
finance.yahoo.com logoCAPRICOR THERAPEUTICS, INC. Financials (OTCMKTS:CAPR)
finance.yahoo.com - December 8 at 1:18 PM
finance.yahoo.com logoCapricor Therapeutics (CAPR) Looks Good: Stock Rises 7.5% (OTCMKTS:CAPR)
finance.yahoo.com - November 27 at 8:00 AM
noodls.com logoCapricor Therapeutics to Present at the 2015 Piper Jaffray Healthcare Conference (OTCMKTS:CAPR)
www.noodls.com - November 24 at 7:11 AM
noodls.com logoBioLife Solutions Customer Capricor Therapeutics Provides Update on Heart Failure Cell Therapy Safety Data at American Heart Association Scientific Sessions (OTCMKTS:CAPR)
www.noodls.com - November 23 at 3:59 PM
biz.yahoo.com logoCAPRICOR THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report (OTCMKTS:CAPR)
biz.yahoo.com - November 13 at 4:32 PM

Social

Capricor Therapeutics (OTCMKTS:CAPR) Chart for Sunday, August, 28, 2016


Last Updated on 8/28/2016 by MarketBeat.com Staff